C-8813

From Wikipedia, the free encyclopedia
  (Redirected from Thiobromadol)
Jump to: navigation, search
C-8813
C-8813.png
Systematic (IUPAC) name
trans-4-(p-Bromophenyl)-4-(dimethylamino)-1-(2-(thiophen-2-yl)ethyl)cyclohexanol
Identifiers
CAS Number 616898-54-5 N
PubChem CID 11058633
Chemical data
Formula C20H26BrNOS
Molar mass 408.394 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

C-8813 (thiobromadol) is a potent μ-opioid receptor agonist with a distinctive chemical structure which is not closely related to other established families of opioid drugs. The trans-isomer was found to be around 591 times more potent than morphine in animal studies.[1] The same study assigned a potency of 504 times that of morphine to the related compound BDPC.

C-8813 is claimed to be similarly potent at the δ-opioid receptor, which antagonizes the mu depression of breathing, presumably making the drug safer.[1]

C-8813 has never been used in humans.

See also[edit]

References[edit]

  1. ^ a b Liu, Z. H.; Jin, W. Q.; Dai, Q. Y.; Chen, X. J.; Zhang, H. P.; Chi, Z. Q. (2003). "Opioid activity of C8813, a novel and potent opioid analgesic". Life Sciences. 73 (2): 233–241. doi:10.1016/S0024-3205(03)00263-7. PMID 12738037. 



Retrieved from "https://en.wikipedia.org/w/index.php?title=C-8813&oldid=683333684"